• Schedule 13D/G History

Soleus Capital Master Fund, L.P. - Significant Ownership

Signature - Title
Soleus Capital Master Fund, L.P. - Guy Levy/Managing Member
Location
Greenwich, CT
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Soleus Capital Master Fund, L.P..

Significant Ownership of Soleus Capital Master Fund, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
THTX THERATECHNOLOGIES INC. Common Stock 10.4% $7.3M 4.8M SOLEUS CAPITAL MASTER FUND, L.P. Apr 11, 2025
JSPR JASPER THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 9.96% $8.05M 1.49M Soleus Capital Management, L.P. Dec 31, 2024
ORGO ORGANOGENESIS HOLDINGS INC. Common Stock, $0.0001 par value per share 9.9% $65.7M 12.5M Soleus Capital Master Fund, L.P. Dec 31, 2024
CELC CELCUITY INC. Common Stock 9.9% $38.8M 3.87M Soleus Capital Master Fund, L.P. Dec 31, 2024
TERN Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 9.6% $27.6M 8.14M Soleus Capital Master Fund, L.P. Dec 31, 2024
VSTM VERASTEM, INC. Common Stock 7.3% $24.2M 3.35M Soleus Capital Management, L.P. Dec 31, 2024
RIGL RIGEL PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share 6.4% $22.1M 1.13M Soleus Capital Master Fund, L.P. Dec 31, 2024
MURA MURAL ONCOLOGY PLC Ordinary Shares, nominal value $0.01 per share 6.3% $1.27M 1.08M Soleus Capital Master Fund, L.P. Apr 15, 2025
STAA STAAR SURGICAL COMPANY Common Stock, $0.01 par value per share 5.2% $44.6M 2.56M Soleus Capital Master Fund, L.P. Mar 26, 2025
SRDX SURMODICS, INC. Common Stock, $0.05 par value per share 5.2% $21.7M 739K Soleus Capital Master Fund, L.P. Jan 21, 2025
EPIX ESSA PHARMA, INC. Common Stock 5.1% $3.89M 2.26M SOLEUS CAPITAL MASTER FUND, L.P. Apr 15, 2025
NVCR NOVOCURE LIMITED Ordinary Shares, no par value per share 5% $118M 5.52M Soleus Capital Master Fund, L.P. Mar 31, 2025
PRAX PRAXIS PRECISION MEDICINES, INC. Common Stock, $0.0001 par value per share 5% $39.3M 1.02M Soleus Capital Master Fund, L.P. Mar 18, 2025

Schedules 13D/G Reported by Soleus Capital Master Fund, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.